Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca
Go back to Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca| Pfizer Inc. (NYSE: PFE) | Delayed: 26.17 +0.57 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.60 | 52 Week High | $37.39 | |||
| Open | $25.79 | 52 Week Low | $28.25 | |||
| Day High | $26.48 | P/E | 15.86 | |||
| Day Low | $25.79 | EPS | $1.65 | |||
| Volume | 45,174,353 | |||||
| Sumitomo Chemical Co Ltd Unsponsored ADR (AMEX: SOMMY) | Delayed: 17.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.00 | 52 Week High | $30.01 | |||
| Open | $17.00 | 52 Week Low | $19.54 | |||
| Day High | $17.00 | P/E | N/A | |||
| Day Low | $17.00 | EPS | $0.00 | |||
| Volume | 52 | |||||
